ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 251

Using the Stroop Word Naming Test and the Mental Clutter Scale in Fibromyalgia Patients to Evaluate the Symptoms of Fibrofog. in Office Testing of Cognitive Complaints

Robert S. Katz1, Lauren Kwan2, Josephine Anilao2, Elizabeth Mitchell2 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: assessment and fibromyalgia

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

We have found that the Stroop word naming test is useful in evaluating fibromyalgia patients with cognitive symptoms, especially in those describing word retrieval problems. It is possible that the slower processing of information may disturb the synchrony of neural circuits and lead to some of the symptoms of cognitive dysfunction in fibromyalgia patients. The Mental Clutter Scale is also valuable in the assessment of cognitive problems.

Methods:

We administered the Stroop word naming test and the Mental Clutter Scale to rheumatic disease patients in a rheumatology office practice.

Results:

There were 28 patients (27 females and 1 male), in the fibromyalgia syndrome group, and 42 (28 females and 14 males), a in the non-fibromyalgia rheumatic disease patient group. The mean age of the fibromyalgia patients was 50.66 years for females and 45 years for males. The mean age of the patients with other rheumatic disease was 53.14 years for females and 48.86 years for males. Fibromyalgia syndrome (FMS) patients met the 2010 ACR criteria for the diagnosis.

The mental clutter score in those with fibromyalgia was 3.8 ± 2.2 and was 2.2 ± 1.6 in patients with other rheumatic diseases, p<0.001

Conclusion:

Fibromyalgia patients have an abnormal Stroop word naming speed. The test is simple to administer. When attempting to evaluate patients with cognitive dysfunction, it can be a helpful test to screen for fibrofog. This test, in addition to the Mental Clutter Scale, can be given in the office, and can help to evaluate patients who are concerned about cognitive dysfunction.

One theory based on the abnormal Stroop test is that fibromyalgia patients appear to be “a beat behind” in their cognitive functioning. Perhaps, when they are sitting at a group meeting, they are not quite following the content because of a slowing of some neural circuits.


Disclosure: R. S. Katz, None; L. Kwan, None; J. Anilao, None; E. Mitchell, None; J. L. Polyak, None.

To cite this abstract in AMA style:

Katz RS, Kwan L, Anilao J, Mitchell E, Polyak JL. Using the Stroop Word Naming Test and the Mental Clutter Scale in Fibromyalgia Patients to Evaluate the Symptoms of Fibrofog. in Office Testing of Cognitive Complaints [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/using-the-stroop-word-naming-test-and-the-mental-clutter-scale-in-fibromyalgia-patients-to-evaluate-the-symptoms-of-fibrofog-in-office-testing-of-cognitive-complaints/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-the-stroop-word-naming-test-and-the-mental-clutter-scale-in-fibromyalgia-patients-to-evaluate-the-symptoms-of-fibrofog-in-office-testing-of-cognitive-complaints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology